Abstract: Identifying differential expression of genes in psoriatic and healthy skin by microarray data analysis is a key approach to understand the pathogenesis of psoriasis. Analysis of more than one dataset to identify genes commonly upregulated reduces the likelihood of false positives and narrows down the possible signature genes. Genes controlling the critical balance between T helper 17 and regulatory T cells are of special interest in psoriasis. Our objectives were to identify genes that are consistently upregulated in lesional skin from three published microarray datasets. We carried out a reanalysis of gene expression data extracted from three experiments on samples from psoriatic and nonlesional skin using the same stringency threshold and software and further compared the expression levels of 92 genes related to the T helper 17 and regulatory T cell signaling pathways. We found 73 probe sets representing 57 genes commonly upregulated in lesional skin from all datasets. These included 26 probe sets representing 20 genes that have no previous link to the etiopathogenesis of psoriasis. These genes may represent novel therapeutic targets and surely need more rigorous experimental testing to be validated. Our analysis also identified 12 of 92 genes known to be related to the T helper 17 and regulatory T cell signaling pathways, and these were found to be differentially expressed in the lesional skin samples.
Introduction
Psoriasis is a common, chronic, inflammatory, relapsing skin disease mediated by T cells, dendritic cells, and several inflammatory cytokines. 1, 2 Recent advances in our knowledge of mechanisms linking innate and adaptive immunity have led to reconsideration of the roles of key players in the pathogenesis of the disease with many uncertainties. 3 Studies of gene expression profiling provide valuable insights into the pathomechanisms involved in psoriasis. The transcriptome from skin biopsies was previously analyzed on microarrays using the 7,000-oligonucleotide array HU6800, the approximately 12,600 element array U95A, the approximately 63,000 probe sets Affymetrix U95A-E arrays, and cDNA arrays. [4] [5] [6] [7] As a result, a number of changes in gene and/or protein expression have been detected in psoriasis, eg, interleukin (IL)-1 and tumor necrosis factor alpha (TNF-α), which were reported to be upregulated with subsequent activation of the NF-κB pathway. 5 It was also noted that Wnt5a and other genes involved in the Wnt signaling pathway are differentially expressed in psoriatic plaques. However, their functional contribution to the pathophysiology of psoriasis needs to be elaborated. 8 Recently, concerns regarding false positives and/or missing This study aims to comprehensively reanalyze microarray gene expression data extracted from three different experiments deposited in the GEO datasets, 8, 15, 16 according to the same criteria. All experiments included skin biopsies from lesional and nonlesional skin, while only two experiments include additional samples from healthy control skin. By reporting genes that are found to be upregulated as a result of the disease in more than one experiment, the possibility of false positives is reduced and the output gene list is refined. We also related our findings to the expression profile of 92 genes (Table 1) 
Materials and methods gene microarray experiments
Data from three experiments with GEO accession numbers, GSE6710, GSE13355, and GSE14905, were extracted from the free PubMed domain (http://www.ncbi.nlm.nih.gov/ gds?term=psoriasis) for further analysis. The GSE6710 experiment 8 includes data from lesional and nonlesional skin samples from 13 individuals with psoriasis and used parent platform GPL96 Affymetrix Human Genome U133A GeneChip ® (Affymetrix, Santa Clara, CA, USA). In the GSE13355 experiment, 15 the parent platform GPL570 Affymetrix Human Genome U133 PLUS 2.0 GeneChip was used and a total of 180 skin samples were profiled, encompassing biopsies from the healthy skin of 64 control subjects and biopsies from the involved and uninvolved skin of 58 patients with psoriasis. In the GSE14905 experiment, 16 the parent platform GPL570 Affymetrix Human Genome U133 Plus 2.0 GeneChip was used and a total of 82 skin samples were profiled (21 normal, 28 uninvolved skin, and 33 lesional skin).
Microarray data analyses
Data files from the above experiments were analyzed with GeneSpring GX11 software (Agilent Technologies, Santa Clara, CA, USA). Ambiguous samples (three samples from GSE6710 and one sample from each of GSE13355 and GSE14905) were excluded by running quality control on each dataset. The data were filtered by expression within the 20-100th percentile, log-transformed, normalized using the Robust Multichip Average algorithm, and baseline converted to the median of all samples. Differential expression in lesional versus nonlesional skin samples was compared using paired Student's t-test statistics with a P-value cutoff #0.05 and a fold change $2.0. To discern further the biological meaning of the output gene lists, we functionally annotated significantly expressed genes on human Kegg pathways using Database for Annotation, Visualization and Integrated Discovery (DAVID) 17 version 6.7 and the HT Human Genome U133 Plus set as background.
For identification of possible interactions between genes of potential importance for the development of psoriasis, network analysis was performed with NetBox 1.0 (cBio, Memorial Sloan-Kettering Cancer Center, New York, NY, USA) (http://cbio.mskcc.org/tools/netbox/netbox.tar.gz). This tool uses human interactions derived from literature- 
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exploring altered expression of T h 17 and T reg signaling in psoriasis curated data sources for prediction of interaction of genes in a submitted gene list. NetBox is preloaded with a human interaction network derived from four literature-curated data sources, including the Human Protein Reference Database, 18 Reactome, 19, 20 NCI-Nature Pathway Interaction Database, 21 and Memorial Sloan-Kettering Cancer Center Cancer Cell Map, and provides the netAnalyse.py method for network analysis, which was described by Cerami et al 22 in 2010. The netAnalyse.py method settings applied during analysis were shortest path threshold =1 and P-value threshold =0.05. The resultant networks were then imported into Cytoscape for further editing and analysis. 23 
Results
Reanalysis of three published microarray datasets 8, 15, 16 revealed a number of probe sets that are differentially expressed (upregulated and/or downregulated) in psoriatic lesional versus nonlesional skin from each experiment, and the Venn diagram in Figure 1 illustrates the intersections between the three experiments. In general, a total of 73 probe sets representing 57 genes were found common to the three datasets and were significantly upregulated in the psoriatic lesions ( Figure 1 , with a complete list in Tables S1 and S2 ). Of these probe sets, only 26 representing 20 genes have no previous reported link to the etiopathogenesis of psoriasis (Table S2) .
We then studied the transcriptional activity underlying the dynamic interplay between the CD4 + T H 17 and CD4 + CD25 high FoxP3 + T Reg cell lineages in the skin of psoriatic patients from the three above experiments. This interplay has recently been linked to the etiopathogenesis of psoriasis and some other autoimmune diseases. 10, 24 A list of 92 genes ( Table 1) that are likely to be involved in the T H 17 and T Reg signaling pathways was prepared. In the first instance, we searched for the differential expression of these genes in the three experiments.
A total of 12 genes were found to be differentially expressed (upregulated/downregulated) in the lesional skin samples with a false discovery rate of ,0.01 and an absolute fold change .2 in at least one of the datasets (Tables 2-4 ). In the data extracted and analyzed from the GSE6710 experiment, 8 five probe sets representing four genes were found to be differentially expressed in the psoriatic lesions, with CD34 being the only example to be downregulated ( Table 2 ). The corresponding profile for the data from GSE13355
15 is a total of nine probe sets/genes that are all upregulated in the lesional versus nonlesional skin (Table 3 ). In the GSE14905 dataset, 16 a total of 12 probe sets representing 11 genes were found to be significantly upregulated in the lesional versus nonlesional skin (Table 4) .
Network analysis was performed on the significantly changed genes reported in Tables 2-4 , S1, and S2. Genes associated with T H 17/T Reg reported in Table 1 were added to this list to aid identification of a possible connection between these genes. The resultant network was then imported into Cytoscape for further analysis. 23 In order to depict possible interactions between genes reported in Tables 2-4 , S1, and S2, the nodes for these genes in the network were enlarged and were colored orange, red (upregulated in psoriasis), or green (downregulated in psoriasis). Identified direct interactions of these genes, which were predicted by the network analysis, were marked as connecting red lines between these nodes ( Figure 2 ). Kotb et al Nodes in these networks were colored according to fold change (green downregulated, yellow-orange-red upregulated) and size of the node indicates relative significance (larger being more significant) ( Figures S1-S3 ).
Discussion
This study confirmed previously reported and newly identified changes in gene transcription in psoriatic skin that might contribute to the etiopathogenesis. Our approach was to reanalyze the microarray raw data deposited in the GEO datasets from three different experiments. 8, 15, 16 Simple comparison of the available published differentially expressed genes from these studies was avoided. This was to ensure consistent analyses rather than rely on different statistical tests and to enforce the same stringency threshold. 25, 26 The use of data extracted from more than one experiment filters out false positives and narrows down the list of genes that show a significantly Network analysis was also performed on significant differentially expressed genes in each of the three data sets investigated, ie, GSE6710, GSE14905, and GSE13355 (significant = two-fold upregulated/downregulated in lesional versus nonlesional skin with a false discovery rate ,0.05).
Psoriasis: Targets and Therapy 2013:3 submit your manuscript | www.dovepress.com
Dovepress

35
exploring altered expression of T h 17 and T reg signaling in psoriasis altered expression level as a result of the disease. Moreover, it decreases the chance of drawing incorrect conclusions because the data are not generated from one laboratory. In 2005, Irizarry et al 27 demonstrated that there are relatively large differences in data obtained from different laboratories, even between those using the same platform, but the results from the best performing laboratories agree rather well.
Genes that show significant overexpression in psoriatic skin were functionally annotated on human Kegg pathways (Tables S1 and S2 ). These genes need further investigation with other techniques and may provide insights into pathogenesis or novel therapeutic targets.
In effect, and despite many efforts, the network of genes that shows significantly altered expression in psoriasis and represents the molecular signature of the disease is still inconspicuous. This is manifested by the relatively high number of recent studies that focused on reanalysis of published data as well as designing new experiments. In 2009, Gudjonsson et al 28 reported some transcriptional differences between uninvolved skin from psoriatic patients as opposed to skin from normal individuals. Cluster analysis of transcripts with significantly altered expression identified a group of genes involved in lipid metabolism with highly correlated gene expression. Their results suggest decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin.
In 2010, the same group 29 performed a gene expression study of 58 paired lesional and uninvolved psoriatic and 64 control skin samples. Comparison of involved psoriatic and 
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Figure 2 network analysis (netanalyse.py method, setting shortest path threshold =1 and P-value threshold =0.05) shows possible interaction between the potential gene targets for treatment of psoriasis as identified in this study. Green circles indicate downregulated genes, orange/red circles indicate upregulated genes and small gray circles indicate part of the T helper 17/regulatory T cell pathway, but were not found to be affected in the experiments analyzed in this study. Lines between nodes show known direct interactions between genes. The network was edited in cytoskape, with a force-directed layout applied. nodes showing affected genes were enlarged and direct interactions between these nodes were highlighted in red to highlight the relevant interactions identified in this analysis in the context of the T helper 17/regulatory T cell pathway. 30 adopted a statistically-based meta-analytic approach, which combines the results of individual studies to overcome the problem of having different lists of differentially expressed genes across experiments due to variations introduced in the microarray pipelines. Their method differs from our approach since we have not combined the disparate microarray studies to derive a single estimate of the overall differential expression level for each gene. Instead, we reanalyzed each individual experiment using the same tools and criteria and listed the differentially expressed genes found in common to overcome the problem of getting false positives. The list of differentially expressed genes found in common is a limited set, and in particular, is limited only to genes featured on the less comprehensive array platform (GPL96 Affymetrix Human Genome U133A GeneChip). Combining data from different experiments into one pool is confounded by the inherent differences in platforms and probe sets and the effects of laboratory conditions. Further, our approach was notably different from others in that we extended our search to test a clinical hypothesis that altered transcriptional activity of the genes controlling the active interplay between T H 17 and T Reg cells is important in disease expression.
Psoriasis
This contemporary paradigm for psoriasis is supported by other recent studies. Krueger et al 31 investigated the effect that neutralization of the T H 17 cell cytokine, IL-17, has on the clinical features of psoriasis using quantitative real-time polymerase chain reaction and microarrays. Their results suggest that IL-17 is a key "driver" cytokine that activates pathogenic inflammation in psoriatic subjects. They also highlighted that neutralizing IL-17 with the anti-IL-17 monoclonal antibody, ixekizumab, might be a successful therapeutic strategy in psoriasis. 31 Concomitantly, two studies 32, 33 have been published in which the gene expression signature was used to stratify lesions and reveal distinct molecular subgroups within the clinical phenotype of plaque psoriasis. This is a new direction that will be very important in developing personalized medication for chronic disease.
Our study is also focused on expression of the genes underlying the balance between T H 17 and T Reg cells. Signal transducer and activator of transcription (STAT3, a member of the JAK-STAT signaling pathway), and the chemokines IL-8 and chemokine (C-C motif) ligand 20 (CCL20) were found to be upregulated in the three experiments. These results are in accordance with previously published data. [34] [35] [36] Recently, Miyoshi et al 37 showed that use of STA-21, a small STAT3 inhibitor, was useful in ameliorating psoriatic skin lesions, not only in K5.Stat3C transgenic mice but also in humans. These results emphasize the importance of targeting STAT3 in the quest for new treatments of psoriasis. Similarly, ABX-IL8 is a fully human IgG 2 monoclonal antibody that binds to human IL-8 with high affinity and specificity and is currently in Phase II clinical investigation for treatment of psoriasis by Abgenix (Fremont, CA, USA). 38 Strikingly, Kim et al 39 found that pretreatment with fluvastatin and simvastatin inhibited migration of human CD4 + T cells towards CCL20 in a chemotaxis migration assay. These findings suggest that these drugs may be of benefit in alleviating psoriasis via interrupting the CCL20/chemokine receptor 6 (CCR6) chemotactic interaction, thus inhibiting infiltration of T H 17 cells.
Other chemokines known to be related to T H 17 and T Reg signaling pathways and found to be differentially upregulated in lesional skin samples in at least one of the three experiments are CCL2, CCL22, chemokine (C-X-C motif) ligand 2 (CXCL2), and matrix metallopeptidase 9 (MMP9). CCL2 is expressed by keratinocytes in both atopic dermatitis and psoriasis and when stimulated with TNF-α and/or interferon gamma (IFN-γ) in a dose-dependent manner.
40 CCL2 binds to the chemokine receptor CCR2 on monocytes and macrophages. CCR2 is overexpressed in monocytes from patients with psoriasis and atopic dermatitis. Thus, CCL2 and CCR2 interaction is likely to be of importance for monocyte/ macrophage trafficking.
CCL22 also belongs to the C-C motif family and is synthesized and secreted by macrophages, dendritic cells, and osteoclasts. It acts selectively on chronically activated lymphocytes by interacting with the CCR4 receptor. Traditionally, CCR4 has been reported to be expressed preferentially on T cells belonging to the Th2 subpopulation. Recent studies have also shown expression of CCR4 on T H 17 cells as well as on T Reg cells. 41 The macrophage-derived chemokine/CCL22 was found to be elevated in the synovial fluid of patients with rheumatoid arthritis and psoriatic arthritis, suggesting that CCR4 could play a role in attracting skin-specific memory T cells to the joints. 
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exploring altered expression of T h 17 and T reg signaling in psoriasis inflammatory process and tissue destruction or contribute by allowing the traffic of inflammatory cells and enhancing the activity of inflammatory cytokines.
CXCL2 was reported to increase by two-fold in psoriatic versus atopic dermatitis skin. 44 Bowcock and Cookson 44 proposed that the higher expression of chemokines in psoriasis is among other factors that could sustain chronic T cell activation and persistence within focal skin regions. Interestingly, our analysis did not show that all genes relating to the T H 17 network (listed in Table 1 ) are differentially expressed in lesional skin. In another similar study 26 where comparison of the expression of psoriasis-related genes across four different studies was conducted, some well recognized inflammatory genes involved in psoriasis, for example, IFN-γ, IL-17, and inducible nitric oxide synthase, were not detected. Using separate polymerase chain reaction, the authors showed that this may be due to low amplification of these genes on the Affymetrix gene array platform (0-4 range of expression in log 2 scale), and hence fold change is not accurately measured. As a positive control, this false negative finding suggests caution in interpreting gene array data. Most analysis pipelines filter out low abundance genes so they may be excluded from the statistical analysis, or the resultant fold change is very low, albeit significant. This is a major limitation of the use of these arrays for the study of these genes. Another possible explanation is that the expression was measured in bulk skin samples containing numerous cell types, and most of these genes are expressed in multiple cell types, so upregulation of a certain gene in one cell type may be neutralized by downregulation in another cell type. 32 CD34, CD3D, and CD8A are the only surface receptor genes from the list in Table 1 that were found to be differentially expressed in psoriatic lesions. CD34 was found in one experiment to be downregulated in lesional versus nonlesional skin (Table 2) .
In our analysis, both CD3D and CD8A were found to be upregulated in lesional versus nonlesional skin. Both genes were previously reported to be downregulated in patients responding to alefacept, the LFA3-Ig fusion protein that binds to CD2. 45 Other genes upregulated in our analysis (listed in Table 1) are IL-1β and IL-7R. In a previous study, 46 IL-lβ was easily detectable by immunofluorescence microscopy and found to be localized predominantly in epidermal keratinocytes. Immunoreactive IL-lβ was found to be elevated in cytosolic extracts derived from involved psoriatic keratomes relative to keratomes of normal skin. The elevated IL-1β protein was accompanied by elevated levels of IL-lβ mRNA in psoriatic skin relative to normal skin. IL-7R expression is also known to increase by at least a two-fold magnitude in the peripheral blood cells of psoriatic patients when measured by cDNA microarray technology. 47 
Conclusion
Studies of gene expression profiling have the potential to greatly improve our understanding of the physiologic and molecular mechanisms underlying the pathogenesis and progression of psoriasis. However, the high chance of getting false positives has become a concern. Reanalysis of data extracted from different experiments using the same software and stringent criteria could reduce this risk and thus refine the list of proposed new therapeutic targets. Our study also highlights the altered expression of genes known to be involved in the control of the T H 17/T Reg balance in psoriatic skin. By reanalyzing repository data and specifically querying these pathways, we provide further evidence that this balance is of key importance in the etiopathogenesis and progression of psoriasis and demonstrate another approach to mining this data. Figure S1 network analysis (netanalyse.py method, setting shortest path threshold =1 and P-value threshold =0.05) shows possible interaction between the potential gene targets for treatment of psoriasis as identified in this study from the GSE6710 experiment. 29 The network was edited in cytoskape, with a force-directed layout applied. Figure S2 network analysis (netanalyse.py method, setting shortest path threshold =1 and P-value threshold =0.05) shows possible interaction between potential gene targets for the treatment of psoriasis as identified in this study from the GSE13355 experiment. 30 The network was edited in cytoskape, with a force-directed layout applied. 
